UNSPSC 51373402: Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51373402 Acetaminophen/caffeine/chlorpheniramine/hydrocodone/phenylephrine is a Commodity code covering prescription and over-the-counter combination pharmaceutical products, though recent state and local activity shows substantial procurement of naloxone and drug deactivation systems alongside broader generic pharmaceuticals. State and local governments buy these products primarily through health departments, county community health systems, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. Issuing bodies range from individual counties managing community health initiatives to statewide cooperative purchasing consortiums facilitating procurement for multiple states and subordinate health agencies.

Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, distributed quarterly to the Seminole County Community Health Building in Sanford, with vendors responsible for shipping and delivery costs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, establishing multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, with proposals due March 26, 2026 and contract effectiveness set for July 1, 2026. Vendors supplying through MMCAP must maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), certify cGMP and Drug Supply Chain Security Act compliance, and accept a 3 percent administrative fee on all purchases. Recent activity centers in Florida and the upper Midwest cooperative purchasing network, though the code's scope appears underspecified relative to the naloxone and OTC pharmaceutical demand actually being solicited.